Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960

Dmitry A Maslov , Marina V Zaĭchikova , Larisa N Chernousova , Kirill V Shur
Tuberculosis 95 ( 5) 608 -612

16
2015
Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis.

Jiayun Liu , Wanliang Shi , Shuo Zhang , Xiaoke Hao
Frontiers in Microbiology 10 216

9
2019
1
2018
5
2022
Transcriptional regulation of drug resistance mechanisms in Salmonella : where we stand and what we need to know

Aqsa Shaheen , Anam Tariq , Aamir Shehzad , Mazhar Iqbal
World Journal of Microbiology & Biotechnology 36 ( 6) 85

11
2020
Repurposing based identification of novel inhibitors against MmpS5-MmpL5 efflux pump of Mycobacterium smegmatis: a combined in silico and in vitro study

Mohd Shahbaaz , Dmitry A Maslov , Aleksey A Vatlin , Valery N Danilenko
Biomedicines 10 ( 2) 333 -333

3
2022
Transcriptomic profile of Mycobacterium smegmatis in response to an Imidazo [1, 2-b][1, 2, 4, 5] tetrazine reveals its possible impact on iron metabolism

Aleksey A Vatlin , Egor A Shitikov , Mohd Shahbaaz , Dmitry A Bespiatykh
Frontiers in Microbiology 12 724042 -724042

2
2021
Synthesis and characterization of novel 2-acyl-3-trifluoromethylquinoxaline 1, 4-dioxides as potential antimicrobial agents

Galina I Buravchenko , Dmitry A Maslov , Md Shah Alam , Natalia E Grammatikova
Pharmaceuticals 15 ( 2) 155 -155

9
2022
Novel Derivatives of Quinoxaline-2-carboxylic Acid 1, 4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential

Svetlana G Frolova , Aleksey A Vatlin , Dmitry A Maslov , Buhari Yusuf
Pharmaceuticals 16 ( 11) 1565 -1565

5
2023
Kanamycin and Ofloxacin Activate the Intrinsic Resistance to Multiple Antibiotics in Mycobacterium smegmatis

Aleksey A Vatlin , Olga B Bekker , Kirill V Shur , Rustem A Ilyasov
Biology 12 ( 4) 506 -506

2023
Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus

Buhari Yusuf , Shuai Wang , Md Shah Alam , Jingran Zhang
Microbiology Spectrum e03974 -23

2024
A Quinoxaline 1, 4-Dioxide Activates DNA Repair Systems in Mycobacterium smegmatis: A Transcriptomic Study

Olga B Bekker , Olesya O Galanova , Aleksey A Vatlin , Svetlana G Frolova

2024
Repurposing based identification of novel inhibitors against MmpS5-MmpL5 efflux pump of Mycobacterium smegmatis: a combined in silico and in vitro study, Biomedicines, 2022, 10 (2), 333

M Shahbaaz , DA Maslov , AA Vatlin , VN Danilenko
s Note: MDPI stays neu-tral with regard to jurisdictional claims in published maps and institu-tional affiliations.

1
2022
Search for potential mycobacterial MmpS5-MmpL5 efflux pump inhibitors

SG Frolova , AA Vatlin , M Shahbaaz , VN Danilenko
FEBS OPEN BIO 11 302 -302

2021
Search for azolo [1, 2, 4, 5] tetrazines biotargets in mycobacteria

DA Maslov , KV Shur , AA Vatlin , OB Bekker
FEBS OPEN BIO 8 263 -263

3
2018
Compilation of the Mycobacterium tuberculosis Beijing-b0 lineage sample and identifying predictors of immune dysfunction in source patients

KV Shur , TV Umpeleva , OB Bekker , DA Maslov
Bulletin of Russian State Medical University ( 3) 23 -28

6
2018
MSMEG_1963 and MSMEG_5597 Genes, but Not inhA, Modulate Mycobacterium smegmatis Resistance to Tryptanthrins

SG Frolova , VN Danilenko , DA Maslov
Russian Journal of Genetics 58 ( 9) 1051 -1058

2022
A novel derivative of quinoxaline-carboxylic acid 1, 4-dioxide as an anti-tubercular drug-candidate

DA Maslov , GI Buravchenko , MS Alam , SG Frolova
FEBS OPEN BIO 12 23 -23

2022
Discovery of novel antimycobacterial agents based on quinoxaline 1, 4-dioxide scaffold

DA Maslov , AA Vatlin , GI Buravchenko , SG Frolova
FEBS OPEN BIO 11 303 -303

2021